Document text
Principal Investigator: TERRY L. SHEPPARD
Organization: KEYSTONE SYMPOSIA
Fiscal Year: 2024
Award: $16,500
Funding agency: National Center for Advancing Translational Sciences
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Delivery of Nucleic Acid Therapeutics,
organized by Drs. Daniel Siegwart and Kathryn Whitehead. The conference will be held in Banff, Alberta,
Canada from January 22-25, 2024.
This conference will bring together world-renowned experts to explore the complex science, engineering, and
application of nucleic acid delivery systems. The recent overwhelming success of mRNA-based SARS-CoV-2
vaccines has refocused attention on the potential of nucleic acids as medicines. Despite steady progress over
decades, the broad application of nucleic acid therapies relies on the development of enabling delivery systems.
This conference will highlight cutting-edge strategies to transport nucleic acids into target cells and organs
without toxicity, address the challenges of delivering nucleic acids systemically and intracellularly and emphasize
exciting clinical applications of nucleic acid delivery technologies. This conference will provide a rare opportunity
to convene experts from a broad array of disciplines, including engineering, materials science, biology,
chemistry, and medicine with a focus on nucleic acid delivery, which will facilitate stimulating conversations that
will guide future development of the field. One aspect that makes this conference completely unique is that it will
be held jointly with another Keystone Symposia meeting entitled “Precision Genome Engineering.” Through the
joint sessions, attendees will hear from leaders in the gene editing field, Drs. Jennifer Doudna and Feng Zhang,
and these and other sessions will facilitate more engagement between these aligned communities. Attendees
will leave the conference with an expanded network of colleagues, armed with a new appreciation for delivery
challenges, solutions, and applications. Ultimately, these experiences will catalyze the development and
execution of new ideas that will bring many more nucleic acid therapies to fruition.
Terms: <2019-nCoV vaccine><ASO therapeutics><ASO therapy><ASO treatment><Address><Alberta><Alberta province><Antisense Oligonucleotide Therapy><Area><Attention><Automobile Driving><Basic Research><Basic Science><Biology><Body Tissues><COVID-19 vaccine><Canada><Cell Body><Cells><Chemistry><Collaborations><Communities><Complex><DNA><Deoxyribonucleic Acid><Development><Discipline><Disease><Disorder><Drug Delivery><Drug Delivery Systems><Drugs><Educational workshop><Engineering><Future><Gene Delivery><Genes><Genetic Medicine><Genome engineering><Hearing><Industrialization><International><Investigators><Joints><Knowledge><Learning><Liver><Medical><Medication><Medicine><Mentors><Messenger RNA><Methodology><Non-Polyadenylated RNA><Nucleic Acids><Organ><Outcome><Pharmaceutical Preparations><RNA><RNA Gene Products><Reagent><Research><Research Personnel><Research Priority><Researchers><Ribonucleic Acid><SARS-CoV-2 vaccine><SARS-coronavirus-2 vaccine><Science><Scientist><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Specificity><System><Technology><Tissues><Toxic effect><Toxicities><Translational Research><Translational Science><Vaccines><Workshop><anti-sense oligonucleotide drug><anti-sense oligonucleotide therapy><anti-sense oligonucleotide treatment><anti-sense therapy><antisense drug><antisense oligonucleotide therapeutic><antisense therapeutics><antisense therapy><clinical applicability><clinical application><clinical practice><conference><convention><coronavirus disease 2019 vaccine><coronavirus disease-19 vaccine><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><driving><drug/agent><experience><hepatic body system><hepatic organ system><improved><mRNA><materials science><meeting><meetings><method development><multidisciplinary><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><novel><nucleic acid delivery><nucleic acid therapy><nucleic acid-based therapeutics><posters><prospective><site targeted delivery><small molecule><success><summit><symposia><symposium><targeted delivery><therapeutic nucleic acids><translation research><translational investigation><vaccine against 2019-nCov><vaccine against COVID-19><vaccine against SARS-CoV-2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine candidates against SARS-CoV-2><vaccine development><vaccine for novel coronavirus><vaccines preventing COVID><vaccines to prevent COVID>